Cargando…
In vitro activities of thiazolidione derivatives combined with daptomycin against clinical Enterococcus faecium strains
BACKGROUND: Previous reports have demonstrated two thiazolidione derivatives (H2-60 and H2-81) can robustly inhibit the planktonic growth and biofilm formation of S. epidermidis and S. aureus by targeting the histidine kinase YycG. Whereas the antibacterial and anti-biofilm activity of these two thi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740470/ https://www.ncbi.nlm.nih.gov/pubmed/34996348 http://dx.doi.org/10.1186/s12866-021-02423-8 |
_version_ | 1784629319940702208 |
---|---|
author | Chen, Zhong Xiong, Yanpeng Tang, Yuanyuan Zhao, Yuxi Chen, Junwen Zheng, Jinxin Wu, Yang Deng, Qiwen Qu, Di Yu, Zhijian |
author_facet | Chen, Zhong Xiong, Yanpeng Tang, Yuanyuan Zhao, Yuxi Chen, Junwen Zheng, Jinxin Wu, Yang Deng, Qiwen Qu, Di Yu, Zhijian |
author_sort | Chen, Zhong |
collection | PubMed |
description | BACKGROUND: Previous reports have demonstrated two thiazolidione derivatives (H2-60 and H2-81) can robustly inhibit the planktonic growth and biofilm formation of S. epidermidis and S. aureus by targeting the histidine kinase YycG. Whereas the antibacterial and anti-biofilm activity of these two thiazolidione derivatives (H2-60 and H2-81) against Enterococcus faecium remains elusive. Here, the pET28a-YycG recombinant plasmid were in vitro expressed in E. coli competent cell BL21 (DE3) and induced to express YycG’ protein (conding HisKA and HATPase_c domain) by 0.5 mM IPTG and was purified by Ni – NTA agarose and then for the autophosphorylation test. Antimicrobial testing and time-killing assay were also be determined. Anti-biofilm activity of two derivatives with sub-MIC concentration towards positive biofilm producers of clinical E. faecium were detected using polystyrene microtiter plate and CLSM. RESULTS: The MICs of H2-60 and H2-81 in the clinical isolates of E. faecium were in the range from 3.125 mg/L to 25 mg/L. Moreover, either H2-60 or H2-81 showed the excellent bactericidal activity against E. faecium with monotherapy or its combination with daptomycin by time-killing assay. E. faecium planktonic cells can be decreased by H2-60 or H2-81 for more than 3 × log10 CFU/mL after 24 h treatment when combined with daptomycin. Furthermore, over 90% of E. faecium biofilm formation could markedly be inhibited by H2-60 and H2-81 at 1/4 × MIC value. In addition, the frequency of the eradicated viable cells embedded in mature biofilm were evaluated by the confocal laser microscopy, suggesting that of H2-60 combined with ampicillin or daptomycin was significantly high when compared with single treatment (78.17 and 74.48% vs. 41.59%, respectively, P < 0.01). CONCLUSION: These two thiazolidione derivatives (H2-60 and H2-81) could directly impact the kinase phosphoration activity of YycG of E. faecium. H2-60 combined with daptomycin exhibit the excellent antibacterial and anti-biofilm activity against E. faecium by targeting YycG. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12866-021-02423-8. |
format | Online Article Text |
id | pubmed-8740470 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-87404702022-01-07 In vitro activities of thiazolidione derivatives combined with daptomycin against clinical Enterococcus faecium strains Chen, Zhong Xiong, Yanpeng Tang, Yuanyuan Zhao, Yuxi Chen, Junwen Zheng, Jinxin Wu, Yang Deng, Qiwen Qu, Di Yu, Zhijian BMC Microbiol Research BACKGROUND: Previous reports have demonstrated two thiazolidione derivatives (H2-60 and H2-81) can robustly inhibit the planktonic growth and biofilm formation of S. epidermidis and S. aureus by targeting the histidine kinase YycG. Whereas the antibacterial and anti-biofilm activity of these two thiazolidione derivatives (H2-60 and H2-81) against Enterococcus faecium remains elusive. Here, the pET28a-YycG recombinant plasmid were in vitro expressed in E. coli competent cell BL21 (DE3) and induced to express YycG’ protein (conding HisKA and HATPase_c domain) by 0.5 mM IPTG and was purified by Ni – NTA agarose and then for the autophosphorylation test. Antimicrobial testing and time-killing assay were also be determined. Anti-biofilm activity of two derivatives with sub-MIC concentration towards positive biofilm producers of clinical E. faecium were detected using polystyrene microtiter plate and CLSM. RESULTS: The MICs of H2-60 and H2-81 in the clinical isolates of E. faecium were in the range from 3.125 mg/L to 25 mg/L. Moreover, either H2-60 or H2-81 showed the excellent bactericidal activity against E. faecium with monotherapy or its combination with daptomycin by time-killing assay. E. faecium planktonic cells can be decreased by H2-60 or H2-81 for more than 3 × log10 CFU/mL after 24 h treatment when combined with daptomycin. Furthermore, over 90% of E. faecium biofilm formation could markedly be inhibited by H2-60 and H2-81 at 1/4 × MIC value. In addition, the frequency of the eradicated viable cells embedded in mature biofilm were evaluated by the confocal laser microscopy, suggesting that of H2-60 combined with ampicillin or daptomycin was significantly high when compared with single treatment (78.17 and 74.48% vs. 41.59%, respectively, P < 0.01). CONCLUSION: These two thiazolidione derivatives (H2-60 and H2-81) could directly impact the kinase phosphoration activity of YycG of E. faecium. H2-60 combined with daptomycin exhibit the excellent antibacterial and anti-biofilm activity against E. faecium by targeting YycG. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12866-021-02423-8. BioMed Central 2022-01-07 /pmc/articles/PMC8740470/ /pubmed/34996348 http://dx.doi.org/10.1186/s12866-021-02423-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Chen, Zhong Xiong, Yanpeng Tang, Yuanyuan Zhao, Yuxi Chen, Junwen Zheng, Jinxin Wu, Yang Deng, Qiwen Qu, Di Yu, Zhijian In vitro activities of thiazolidione derivatives combined with daptomycin against clinical Enterococcus faecium strains |
title | In vitro activities of thiazolidione derivatives combined with daptomycin against clinical Enterococcus faecium strains |
title_full | In vitro activities of thiazolidione derivatives combined with daptomycin against clinical Enterococcus faecium strains |
title_fullStr | In vitro activities of thiazolidione derivatives combined with daptomycin against clinical Enterococcus faecium strains |
title_full_unstemmed | In vitro activities of thiazolidione derivatives combined with daptomycin against clinical Enterococcus faecium strains |
title_short | In vitro activities of thiazolidione derivatives combined with daptomycin against clinical Enterococcus faecium strains |
title_sort | in vitro activities of thiazolidione derivatives combined with daptomycin against clinical enterococcus faecium strains |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740470/ https://www.ncbi.nlm.nih.gov/pubmed/34996348 http://dx.doi.org/10.1186/s12866-021-02423-8 |
work_keys_str_mv | AT chenzhong invitroactivitiesofthiazolidionederivativescombinedwithdaptomycinagainstclinicalenterococcusfaeciumstrains AT xiongyanpeng invitroactivitiesofthiazolidionederivativescombinedwithdaptomycinagainstclinicalenterococcusfaeciumstrains AT tangyuanyuan invitroactivitiesofthiazolidionederivativescombinedwithdaptomycinagainstclinicalenterococcusfaeciumstrains AT zhaoyuxi invitroactivitiesofthiazolidionederivativescombinedwithdaptomycinagainstclinicalenterococcusfaeciumstrains AT chenjunwen invitroactivitiesofthiazolidionederivativescombinedwithdaptomycinagainstclinicalenterococcusfaeciumstrains AT zhengjinxin invitroactivitiesofthiazolidionederivativescombinedwithdaptomycinagainstclinicalenterococcusfaeciumstrains AT wuyang invitroactivitiesofthiazolidionederivativescombinedwithdaptomycinagainstclinicalenterococcusfaeciumstrains AT dengqiwen invitroactivitiesofthiazolidionederivativescombinedwithdaptomycinagainstclinicalenterococcusfaeciumstrains AT qudi invitroactivitiesofthiazolidionederivativescombinedwithdaptomycinagainstclinicalenterococcusfaeciumstrains AT yuzhijian invitroactivitiesofthiazolidionederivativescombinedwithdaptomycinagainstclinicalenterococcusfaeciumstrains |